Judson Gary and Genard Hajdini
This paper deals with stem cell boogies and longevity market on the DNA gene therapy business. In Dr. James Canton’s book, The Extreme Future, the author mentions several health cures and enhancement ideas that stemcell treatments may offer in twenty years: 1) New organs, including hearts and lungs; 2) New bone growth for legs, arms, and backs; 3) New sensory functions and optic nerves to restore eyesight; 4) New cancer treatments; 5) New nerves to heal muscles and to restore movement; 6) New cells to offset the aging brain. Since, James Watson and Francis Crick discovered and published the book The Double Helix (1968), DNA; the health sciences have had an incredible boom and growth. DNA is the basics of life’s inheritance, and most of the modern health innovations are due to its understanding. “Life-extension treatments, from genetic vaccines and designer DNA ‘surgery’ to smart drugs and neuro-medical devices, will augment health, improving intelligence, and maximizing beauty” [1].
A clear picture of what is ahead is also given also by James Martin a rocket scientist in his book: The Meaning of the 21st Century, on gene therapy or “genetically modified humans,” as well as shedding light on our other topic of “the magic of stem cells.” This report is written for Departmental Heads of the Institute of Public Health (IPH) in Albania, who are in position of developing future healthcare policies, and supporting development programs of “adult stem cells” and “genetic engineering” cures for population at large. The interested investors will be the healthcare insurance companies, public health officials, and tertiary hospital caregivers in the healthcare industry, which will join in a Public-Private-Partnership (PPP) to achieve the desired results to cure damaged tissues of the human body and heal genetically inherited disease by gene splicing and insertion, also known as transplanting genes.
分享此文章
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 